Acetylsalicylic Acid

Direct oral anticoagulation versus aspirin after ESUS: next investigational steps 2:10
Direct oral anticoagulation versus aspirin after ESUS: next investigational steps
Sven Poli • 20 Feb 2023
ATTICUS subgroup analyses indicate superiority of apixaban over aspirin 5:43
ATTICUS subgroup analyses indicate superiority of apixaban over aspirin
Sven Poli • 20 Feb 2023
Direct oral anticoagulants after stroke: ongoing clinical trials 3:10
Direct oral anticoagulants after stroke: ongoing clinical trials
Edip Gurol • 2 Apr 2022
ATTICUS trial of apixaban vs aspirin for secondary prevention after ESUS: findings & implications 22:22
ATTICUS trial of apixaban vs aspirin for secondary prevention after ESUS: findings & implications
Sven Poli et al. • 20 May 2022
Lacunar stroke: acute treatment and secondary prevention 2:19
Lacunar stroke: acute treatment and secondary prevention
Francesco Arba • 4 May 2022
CHANCE-2: ticagrelor versus clopidogrel in CYP2C19 allele carriers 1:44
CHANCE-2: ticagrelor versus clopidogrel in CYP2C19 allele carriers
S. Claiborne Johnston • 7 Sep 2021
Expedited recommendation for short-term dual antiplatelet therapy after minor stroke & high-risk TIA 1:48
Expedited recommendation for short-term dual antiplatelet therapy after minor stroke & high-risk TIA
Ana Catarina Fonseca • 6 Sep 2021
Ischemic benefit vs. hemorrhagic risk in the THALES dual antiplatelet therapy trial 2:05
Ischemic benefit vs. hemorrhagic risk in the THALES dual antiplatelet therapy trial
S. Claiborne Johnston • 7 Sep 2021
Key updates on pediatric and adolescent headache practice guidelines 3:41
Key updates on pediatric and adolescent headache practice guidelines
Andrew Hershey • 2 Sep 2021
Promising clinical trials in CBI: ENVIS-ion study 1:06
Promising clinical trials in CBI: ENVIS-ion study
Thomas Meinel • 7 Jun 2021
The content of VJNeurology is intended for healthcare professionals